» Articles » PMID: 8905180

Increased Iron in the Substantia Nigra of 6-OHDA Induced Parkinsonian Rats: a Nuclear Microscopy Study

Overview
Journal Brain Res
Specialty Neurology
Date 1996 Sep 30
PMID 8905180
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The trace elemental concentrations, including iron, in the substantia nigra (SN) of a 6-OHDA induced rat model of Parkinson's disease were measured using nuclear microscopy. Only rats that exhibited amphetamine induced rotation of more than 7 turns/min were used. The results showed that the iron levels were significantly increased in the 6-OHDA lesioned SN, compared with the intact contralateral SN, and the SN of normal control rats injected with ascorbic acid, which showed no significant difference in iron levels between injected and non-injected sides. In both 6-OHDA lesioned and ascorbic acid injected SN, there were no alterations in the levels of calcium, magnesium, copper and zinc. In the 6-OHDA lesioned SN there was an almost complete loss of tyrosine hydroxylase positive cells in the SN. These results suggested that the 6-OHDA induced dopaminergic cell death may be related to the increased iron.

Citing Articles

The Pathopharmacological Interplay between Vanadium and Iron in Parkinson's Disease Models.

Ohiomokhare S, Olaolorun F, Ladagu A, Olopade F, Howes M, Okello E Int J Mol Sci. 2020; 21(18).

PMID: 32937783 PMC: 7554808. DOI: 10.3390/ijms21186719.


Mapping Chemical Elements and Iron Oxidation States in the Substantia Nigra of 6-Hydroxydopamine Lesioned Rats Using Correlative Immunohistochemistry With Proton and Synchrotron Micro-Analysis.

Carmona A, Roudeau S, Perrin L, Carcenac C, Vantelon D, Savasta M Front Neurosci. 2019; 13:1014.

PMID: 31680798 PMC: 6798047. DOI: 10.3389/fnins.2019.01014.


Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.

Mouhape C, Costa G, Ferreira M, Abin-Carriquiry J, Dajas F, Prunell G Neurotox Res. 2018; 35(1):71-82.

PMID: 30006684 DOI: 10.1007/s12640-018-9931-1.


Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Jiang H, Wang J, Rogers J, Xie J Mol Neurobiol. 2016; 54(4):3078-3101.

PMID: 27039308 DOI: 10.1007/s12035-016-9879-1.


The effects of prenatal methylmercury exposure on trace element and antioxidant levels in rats following 6-hydroxydopamine-induced neuronal insult.

Mohamed Moosa Z, Daniels W, Mabandla M Metab Brain Dis. 2013; 29(2):459-69.

PMID: 24338101 DOI: 10.1007/s11011-013-9465-4.